Mucosal leishmaniasis: Description of case management approaches and analysis of risk factors for treatment failure in a cohort of 140 patients in Brazil

Journal of the European Academy of Dermatology and Venereology

Volumn 23, Issue 9, 2009, Pages 1026-1034

  Amato, V S ^a   Tuon, F F ^a   Imamura, R ^a   Abegao De Camargo R ^a   Duarte, M I ^a   Neto, V A ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Epidemiology; Leishmania; Leishmaniasis; Mucosal leishmaniasis; Treatment; Tropical diseases

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B DEOXYCHOLATE; AMPHOTERICIN B LIPID COMPLEX; ITRACONAZOLE; MEGLUMINE ANTIMONATE; NEOITRAX; NEXTAR; PENTAMIDINE; SIDERON; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ALLERGY; ARTICLE; BLOOD CLOTTING DISORDER; BRAZIL; CHRONIC KIDNEY DISEASE; CLINICAL FEATURE; DIABETES MELLITUS; DRUG TREATMENT FAILURE; EPISTAXIS; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; HYPERTENSION; IMMUNOHISTOCHEMISTRY; INFECTION RATE; INFECTION RISK; LEISHMANIA BRAZILIENSIS; LEISHMANIN SKIN TEST; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PARASITE IDENTIFICATION; PRIORITY JOURNAL; RECURRENCE RISK; RHINORRHEA; RISK ASSESSMENT; SEROLOGY; SKIN LEISHMANIASIS; TREATMENT RESPONSE; VIRUS HEPATITIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANIMALS; ANTIPROTOZOAL AGENTS; BRAZIL; CASE MANAGEMENT; COHORT STUDIES; FEMALE; HUMANS; HYPERTENSION; ITRACONAZOLE; LEISHMANIA BRAZILIENSIS; LEISHMANIASIS, MUCOCUTANEOUS; LOGISTIC MODELS; MALE; MEGLUMINE; MIDDLE AGED; PENTAMIDINE; RECURRENCE; RETROSPECTIVE STUDIES; RISK FACTORS; SKIN; TREATMENT FAILURE; YOUNG ADULT;

EID: 68749111244     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2009.03238.x     Document Type: Article

References (36)

1. Schwartz E, Hatz C, Blum J. New world cutaneous leishmaniasis in travellers. Lancet Infect Dis 2006 6 : 342 349.
2. Reithinger R, Dujardin JC, Louzir H, Pirmez C, Alexander B, Brooker S. Cutaneous leishmaniasis. Lancet Infect Dis 2007 7 : 581 596.
3. Boaventura VS, Cafe V, Costa J et al. Concomitant early mucosal and cutaneous leishmaniasis in Brazil. Am J Trop Med Hyg 2006 75 : 267 269.
4. Amato VS, Tuon FF, Bacha HA, Neto VA, Nicodemo AC. Mucosal leishmaniasis Current scenario and prospects for treatment. Acta Trop 2008 105 (1 1 9.
5. Amato VS, Boulos MI, Amato N, V. Filomeno LT. The use of a silicone T tube for the treatment of a case of American mucocutaneous leishmaniasis with tracheomalacia. Rev Soc Bras Med Trop 1995 28 : 129 130.
6. Marsden PD. Mucosal leishmaniasis ('espundia' Escomel, 1911). Trans R Soc Trop Med Hyg 1986 80 : 859 876.
7. Rodrigues AM, Hueb M, Santos TA, Fontes CJ. Factors associated with treatment failure of cutaneous leishmaniasis with meglumine antimoniate. Rev Soc Bras Med Trop 2006 39 : 139 145.
8. Reis LC, de Brito ME, de Almeida EL et al. Clinical, epidemiological and laboratory aspects of patients with American cutaneous leishmaniasis in the State of Pernambuco. Rev Soc Bras Med Trop 2008 41 : 439 443.
9. Tuon FF, Amato VS, Floeter-Winter LM et al. Cutaneous leishmaniasis reactivation 2 years after treatment caused by systemic corticosteroids - first report. Int J Dermatol 2007 46 : 628 630.
10. Amato VS, Andrade HF, Amato N, V. Duarte MI. Short report: persistence of tumor necrosis factor-alpha in situ after lesion healing in mucosal leishmaniasis. Am J Trop Med Hyg 2003 68 : 527 528.
11. Llanos-Cuentas A, Echevarria J, Cruz M et al. Efficacy of sodium stibogluconate alone and in combination with allopurinol for treatment of mucocutaneous leishmaniasis. Clin Infect Dis 1997 25 : 677 684.
12. Couppie P, Clyti E, Sobesky M et al. Comparative study of cutaneous leishmaniasis in human immunodeficiency virus (HIV) -infected patients and non-HIV-infected patients in French Guiana. Br J Dermatol 2004 151 : 1165 1171.
13. Sanchez P, Bosch RJ, de Galvez MV, Rodrigo AB, Herrera E. Mucocutaneous leishmaniasis in a patient with the human immunodeficiency virus. Int J STD AIDS 2001 12 : 687 689. (Pubitemid 32964354)
14. Borges AS, Machado AA, Ferreira MS et al. Concurrent leishmaniasis and human immunodeficiency virus (HIV) infection: a study of four cases. Rev Soc Bras Med Trop 1999 32 : 713 719.
15. de Souza AR, Costa A, Nakamura D, Mocheti LN, Stevanato Filho PR, Ovando LA. A study on systemic arterial hypertension in Campo Grande, MS, Brazil. Arq Bras Cardiol 2007 88 : 441 446.
16. Riviere G, Michaud A, Corradi HR et al. Characterization of the first angiotensin-converting like enzyme in bacteria: Ancestor ACE is already active. Gene 2007 399 : 81 90.
17. Goyal N, Roy U, Rastogi AK. Relative resistance of promastigotes of a virulent and an avirulent strain of Leishmania donovani to hydrogen peroxide. Free Radic Biol Med 1996 21 : 683 689.
18. Ohta K, Kim S, Hamaguchi A et al. Role of angiotensin II in extracellular matrix and transforming growth factor-beta 1 expression in hypertensive rats. Eur J Pharmacol 1994 269 : 115 119.
19. Barral A, Teixeira M, Reis P et al. Transforming growth factor-beta in human cutaneous leishmaniasis. Am J Pathol 1995 147 : 947 954.
20. Amato VS, de Andrade HF, Duarte MI. Mucosal leishmaniasis: in situ characterization of the host inflammatory response, before and after treatment. Acta Trop 2003 85 : 39 49.
21. Rodrigues AM, Hueb M, Nery AF, Fontes CJ. Possible cardioprotective effect of angiotensin-converting enzyme inhibitors during treatment of American tegumentary leishmaniasis with meglumine antimoniate. Acta Trop 2007 102 : 113 118.
22. Santos JB, Lauand L, Souza GS, Macedo VO. Socioeconomic factors and attitudes towards household prevention of American cutaneous leishmaniasis in an endemic area in Southern Bahia, Brazil. Cad Saude Publica 2000 16 : 701 708.
23. Amato V, Amato J, Nicodemo A, Uip D, Amato Neto V, Duarte M. Treatment of mucocutaneous leishmaniasis with pentamidine isothionate. Ann Dermatol Venereol 1998 125 : 492 495.
24. Amato VS, de Paula JG, Imamura R et al. Treatment of american cutaneous leishmaniasis, with lesions in the mucosa, using pentamidine isethionate. Rev Soc Bras Med Trop 1996 29 : 477 481.
25. Llanos-Cuentas A, Echevarria J, Seas C et al. Parenteral aminosidine is not effective for peruvian mucocutaneous leishmaniasis. Am J Trop Med Hyg 2007 76 : 1128 1131.
26. Romero GA, Lessa HA, Orge MG, Macedo VO, Marsden PD. Treatment of mucosal leishmaniasis with aminosidine sulfate: results of two year follow-up. Rev Soc Bras Med Trop 1998 31 : 511 516.
27. Corredor A, Kreutzer RD, Tesh RB et al. Distribution and etiology of leishmaniasis in Colombia. Am J Trop Med Hyg 1990 42 : 206 214.
28. Bacaer N, Guernaoui S. The epidemic threshold of vector-borne diseases with seasonality: the case of cutaneous leishmaniasis in Chichaoua, Morocco. J Math Biol 2006 53 : 421 436.
29. Cuba Cuba CA, Miles MA, Vexenat A et al. A focus of mucocutaneous leishmaniasis in Tres Bracos, Bahia, Brazil: characterization and identification of Leishmania stocks isolated from man and dogs. Trans R Soc Trop Med Hyg 1985 79 : 500 507.
30. Castro EA, Thomaz-Soccol V, Augur C, Luz E. Leishmania (Viannia) braziliensis: epidemiology of canine cutaneous leishmaniasis in the State of Parana (Brazil). Exp Parasitol 2007 117 : 13 21.
31. Belkaid Y, Mendez S, Lira R, Kadambi N, Milon G, Sacks D. A natural model of Leishmania major infection reveals a prolonged 'silent' phase of parasite amplification in the skin before the onset of lesion formation and immunity. J Immunol 2000 165 : 969 977.
32. Machado-Coelho GL, Caiaffa WT, Genaro O, Magalhaes PA, Mayrink W. Risk factors for mucosal manifestation of American cutaneous leishmaniasis. Trans R Soc Trop Med Hyg 2005 99 : 55 61.
33. Amato VS, Tuon FF, Siqueira AM, Nicodemo AC, Amato Neto V. Treatment of mucosal leishmaniasis in Latin America: systematic review. Am J Trop Med Hyg 2007 77 : 266 274.
34. Amato VS, Tuon FF, Campos A et al. Treatment of mucosal leishmaniasis with a lipid formulation of amphotericin B. Clin Infect Dis 2007 44 : 311 312.
35. Tuon FF, Amato VS. Mucosal leishmaniasis and miltefosine. Clin Infect Dis 2007 44 : 1525 1526.
36. Guimaraes MC, Celeste BJ, Franco EL, Cuce LC, Belda W Jr. Evaluation of serological diagnostic indices for mucocutaneous leishmaniasis: immunofluorescence tests and enzyme-linked immunoassays for IgG, IgM and IgA antibodies. Bull World Health Organ 1989 67 : 643 648.